title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Marinus  ( MRNS )  to Sell Rare Disease PRV to Novo Nordisk,20220715T154300,https://www.zacks.com/stock/news/1953027/marinus-mrns-to-sell-rare-disease-prv-to-novo-nordisk,MRNS,0.254307,Bullish,0.367242
74 Biggest Movers From Yesterday,20220603T095047,https://www.benzinga.com/news/22/06/27539006/74-biggest-movers-from-yesterday,MRNS,0.079234,Neutral,-0.036277
"Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs",20221024T113000,https://www.globenewswire.com/news-release/2022/10/24/2539849/0/en/Reunion-Neuroscience-Appoints-Chief-Financial-Officer-and-Vice-President-Medical-Affairs.html,MRNS,0.036812,Neutral,0.02085
"Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs - Reunion Neuroscience  ( NASDAQ:REUN ) ",20221024T113000,https://www.benzinga.com/pressreleases/22/10/g29376187/reunion-neuroscience-appoints-chief-financial-officer-and-vice-president-medical-affairs,MRNS,0.035086,Neutral,0.020685
"The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures",20220714T130111,https://www.benzinga.com/general/biotech/22/07/28062629/the-daily-biotech-pulse-much-awaited-fda-nod-for-novavaxs-covid-19-shot-dsmb-suggests-contrafect-,MRNS,0.114137,Neutral,0.096488
"The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More",20220512T124254,https://www.benzinga.com/general/biotech/22/05/27161064/the-daily-biotech-pulse-bristol-myers-bridgebio-ink-oncology-pact-fda-nod-for-lava-therapeutics-b,MRNS,0.080525,Neutral,-0.002217
